글로벌 규제조화 지원센터

입법/행정예고

> 글로벌 인허가 규제정보 > 해외법령 > 입법/행정예고
구분 유럽 등록일 21.03.17
제목 [유럽, TBT통보문] 징크피리치온, 부틸페닐메틸프로피오날 등 Annex II(배합금지), III(배합한도), V(보존제) 개정안
첨부파일 (별첨1) EU773_TBT통보문(영문).pdf
(별첨2) EU773_개정내용(영문).pdf
(별첨3) EU773_개정안(영문).pdf
바로가기 http://tbtims.wto.org/en/RegularNotifications/View/170033?FromAllNotifications=True

 

제목(영문) : Draft Commission Regulation amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction (4 page(s), in English; 4 page(s), in English)

 

주요내용 : The draft measure is required to enact the prohibition to use as cosmetic ingredients substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR) by Commission Regulation (EU) No 2020/1182, which has been adopted based on Regulation (EC) No 1272/2008 (the CLP Regulation) and will apply from 1 March 2022. The adoption of this draft Regulation is, therefore, needed to reflect inRegulation (EC) No 1223/2009(the Cosmetics Regulation) the new CMRs classification provided by Commission Regulation (EU) No 2020/1182, in order to ensure legal certainty and a high level of protection of human health.

 

Proposed date of adoption: 3rd quarter 2021

 

Proposed date of entry into force: 20 days from publication in the Official Journal of the EU

이전글 [대만, TBT통보문] 대만 화장품 미생물 기준 개정안
다음글 [유럽, TBT통보문] 티타늄디옥사이드, 살리실릭애씨드, CMR물질 등 Annex II(배합금지), III(배합한도), IV(착색제), VI자외선차단제) 개정안